UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High-Dose Intra-Arterial Cisplatin Boost With Hyperfractionated Radiation Therapy for Advanced Squamous Cell Carcinoma of the Head and Neck

Journal of clinical oncology, 2001-07, Vol.19 (14), p.3333-3339

2001

Volltextzugriff (PDF)

Excellent long-term control in locoregionally recurrent radioactive iodine-refractory papillary thyroid cancer with the addition of external beam radiation therapy to maximal surgical resection

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e16035-e16035

2012

Volltextzugriff (PDF)

Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Long-Acting Methylphenidate for Cancer-Related Fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial

Journal of clinical oncology, 2010-08, Vol.28 (23), p.3673-3679

2010

Volltextzugriff (PDF)

Phase III, Placebo-Controlled Trial of Three Doses of Citalopram for the Treatment of Hot Flashes: NCCTG Trial N05C9

Journal of clinical oncology, 2010-07, Vol.28 (20), p.3278-3283

2010

Volltextzugriff (PDF)

Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation on the Erythropoietic Response to Darbepoetin Alfa for Patients With Chemotherapy-Associated Anemia

Journal of clinical oncology, 2011-01, Vol.29 (1), p.97-105

2011

Volltextzugriff (PDF)

Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Advanced Cancer

Journal of clinical oncology, 2005-02, Vol.23 (6), p.1078-1087

2005

Volltextzugriff (PDF)

Patient, caregiver, and provider reported risk-benefit acceptance thresholds in non-muscle invasive bladder cancer (NMIBC) trial designs

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.424-424

2021

Volltextzugriff (PDF)

ABLE: Phase 2, single-arm, two-stage study of nabpaclitaxel with anti-PD1/PDL1 in advanced urothelial cancer

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.502-502

2022

Volltextzugriff (PDF)

The effect of race on adherence to NCCN Guidelines for patients with biliary tract cancers (BTC) after surgery

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e15686-e15686

2019

Volltextzugriff (PDF)

The impact of sorafenib on the treatment and survival of advanced hepatocellular carcinoma (HCC): Analysis of the National Cancer Database (NCDB) from 2004 to 2014

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e15682-e15682

2019

Volltextzugriff (PDF)

Impact of facility type, insurance status, and income on use of single agent chemotherapy (SACT) for advanced hepatocellular carcinoma (AHCC): Analysis of National Cancer Database (NCDB)

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.504-504

2020

Volltextzugriff (PDF)

Impact of BRAF mutations on outcomes in metastatic melanoma with central nervous system metastases treated with immune checkpoint inhibitors

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e21500-e21500

2021

Volltextzugriff (PDF)

Outcomes of melanoma patients with brain metastases receiving immune checkpoint inhibitor (ICI) therapy

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e21028-e21028

2019

Volltextzugriff (PDF)

Phase III Study of Two Different Dosing Schedules of Erythropoietin in Anemic Patients With Cancer

Journal of clinical oncology, 2006-03, Vol.24 (7), p.1079-1089

2006

Volltextzugriff (PDF)

Phase I clinical trial of the glutaminase inhibitor CB-839 plus capecitabine in patients with advanced solid tumors

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.2562-2562

2018

Volltextzugriff (PDF)

Decision aids for localized prostate cancer: Initial outcomes from NCI Community Oncology Research Program Alliance Research Base Cancer Care Delivery Research (CCDR) Protocol - A191402CD - A Cluster-Randomized Trial

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e24176-e24176

2020

Volltextzugriff (PDF)

Issues and Challenges With Integrating Patient-Reported Outcomes in Clinical Trials Supported by the National Cancer Institute–Sponsored Clinical Trials Networks

Journal of clinical oncology, 2007-11, Vol.25 (32), p.5051-5057

2007

Volltextzugriff (PDF)

Incidence and survival of dermatofibrosarcoma protuberans in the United States

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.9037-9037

2014

Volltextzugriff (PDF)

Reply to M. Aapro et al

Journal of clinical oncology, 2011-06, Vol.29 (17), p.e527-e528

2011

Volltextzugriff (PDF)

Impact of vaginal dehydroepiandosterone (DHEA) on vaginal symptoms in female cancer survivors: Trial N10C1 (Alliance)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.9507-9507

2014

Volltextzugriff (PDF)

Health and quality of life (QOL) issues in four groups of lung cancer patients: Low-dose computed tomography (LDCT) screened, chest x-ray detected, incidentally found, and routinely diagnosed

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.1610-1610

2012

Volltextzugriff (PDF)

Patient satisfaction with participation in phase II/III NCCTG clinical trials: Was it worth it? (N0392)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.6133-6133

2012

Volltextzugriff (PDF)

Next-generation sequencing to identify mutations that may predict outcome after allogeneic stem cell transplantation for AML

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.7043-7043

2014

Volltextzugriff (PDF)

Quality of life (QOL) among patients (pts) with HER2+ breast cancer (bc) treated with adjuvant lapatinib and/or trastuzumab in the ALTTO study (BIG 2-06, Alliance N063D)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.647-647

2014

Volltextzugriff (PDF)

A randomized, double‑blind, controlled phase IIb study of the safety and efficacy of ICT‑107 in newly diagnosed patients with glioblastoma multiforme following resection and chemoradiation

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.TPS2107-TPS2107

2012

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(27)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(7)
Humans
(7)
Life Sciences & Biomedicine
(7)
Medical Sciences
(7)
Oncology
(7)
Science & Technology
(7)
Female
(6)
Middle Aged
(6)
Tumors
(6)
Male
(5)
Aged
(4)
Adult
(3)
Antineoplastic Agents - Administration & Dosage
(3)
Antineoplastic Agents - Adverse Effects
(3)
Drug Administration Schedule
(3)
Original Reports
(3)
Quality Of Life
(3)
Treatment Outcome
(3)
Anemias. Hemoglobinopathies
(2)
Antineoplastic Agents - Therapeutic Use
(2)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High-Dose Intra-Arterial Cisplatin Boost With Hyperfractionated Radiation Therapy for Advanced Squamous Cell Carcinoma of the Head and Neck

Excellent long-term control in locoregionally recurrent radioactive iodine-refractory papillary thyroid cancer with the addition of external beam radiation therapy to maximal surgical resection

Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Long-Acting Methylphenidate for Cancer-Related Fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial

Phase III, Placebo-Controlled Trial of Three Doses of Citalopram for the Treatment of Hot Flashes: NCCTG Trial N05C9

Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation on the Erythropoietic Response to Darbepoetin Alfa for Patients With Chemotherapy-Associated Anemia

Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Advanced Cancer

Patient, caregiver, and provider reported risk-benefit acceptance thresholds in non-muscle invasive bladder cancer (NMIBC) trial designs

ABLE: Phase 2, single-arm, two-stage study of nabpaclitaxel with anti-PD1/PDL1 in advanced urothelial cancer

The effect of race on adherence to NCCN Guidelines for patients with biliary tract cancers (BTC) after surgery

The impact of sorafenib on the treatment and survival of advanced hepatocellular carcinoma (HCC): Analysis of the National Cancer Database (NCDB) from 2004 to 2014

Impact of facility type, insurance status, and income on use of single agent chemotherapy (SACT) for advanced hepatocellular carcinoma (AHCC): Analysis of National Cancer Database (NCDB)

Impact of BRAF mutations on outcomes in metastatic melanoma with central nervous system metastases treated with immune checkpoint inhibitors

Outcomes of melanoma patients with brain metastases receiving immune checkpoint inhibitor (ICI) therapy

Phase III Study of Two Different Dosing Schedules of Erythropoietin in Anemic Patients With Cancer

Phase I clinical trial of the glutaminase inhibitor CB-839 plus capecitabine in patients with advanced solid tumors

Decision aids for localized prostate cancer: Initial outcomes from NCI Community Oncology Research Program Alliance Research Base Cancer Care Delivery Research (CCDR) Protocol - A191402CD - A Cluster-Randomized Trial

Issues and Challenges With Integrating Patient-Reported Outcomes in Clinical Trials Supported by the National Cancer Institute–Sponsored Clinical Trials Networks

Incidence and survival of dermatofibrosarcoma protuberans in the United States

Reply to M. Aapro et al

Impact of vaginal dehydroepiandosterone (DHEA) on vaginal symptoms in female cancer survivors: Trial N10C1 (Alliance)

Health and quality of life (QOL) issues in four groups of lung cancer patients: Low-dose computed tomography (LDCT) screened, chest x-ray detected, incidentally found, and routinely diagnosed

Patient satisfaction with participation in phase II/III NCCTG clinical trials: Was it worth it? (N0392)

Next-generation sequencing to identify mutations that may predict outcome after allogeneic stem cell transplantation for AML

Quality of life (QOL) among patients (pts) with HER2+ breast cancer (bc) treated with adjuvant lapatinib and/or trastuzumab in the ALTTO study (BIG 2-06, Alliance N063D)

A randomized, double‑blind, controlled phase IIb study of the safety and efficacy of ICT‑107 in newly diagnosed patients with glioblastoma multiforme following resection and chemoradiation

Aktive Filter

Suchergebnisse filtern